Edwards Lifesciences Corp (EW) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues | 1.46%1,715.50 | 1,741.00 | 1,648.60 | 1,569.60 | 1,553.10 |
| Cost Of Revenue | 5.91%369.20 | 392.40 | 362.60 | 343.00 | 345.20 |
| Gross Profit | 0.17%1,346.30 | 1,348.60 | 1,286.00 | 1,226.60 | 1,207.90 |
0.05%560.90 | 561.20 | 522.20 | - | - | |
| Selling, General, and Administrative | 0.05%560.90 | 561.20 | 522.20 | - | - |
| Research and Development | 0.90%281.40 | 278.90 | 263.30 | - | - |
| Operating Income/Loss | 41.72%299.10 | 513.20 | 477.60 | 151.10 | 307.10 |
| Net Interest Income/Expense | 21.67%36.50 | 30.00 | 33.50 | -132.90 | 38.60 |
| Nonoperating Income/Loss | 871.21%64.10 | 6.60 | -18.60 | -60.70 | 41.30 |
| Income/Loss From Continuing Operations Before Tax | 30.13%363.20 | 519.80 | 459.00 | 90.40 | 348.40 |
| Income Tax Expense/Benefit | 77.80%61.80 | 278.40 | 78.30 | 26.20 | 56.10 |
| Income/Loss From Continuing Operations After Tax | 24.86%301.40 | 241.40 | 380.70 | 64.20 | 292.30 |
| Income/Loss From Discontinued Operations, Net Of Tax | - | - | - | 27.00 | -2.00 |
24.86%301.40 | 241.40 | 380.70 | 91.20 | 290.30 | |
| Attributable To Parent | 27.12%307.50 | 241.90 | 380.70 | 91.20 | 291.10 |
| Attributable To Noncontrolling Interest | 1,120%-6.10 | -0.50 | - | - | -0.80 |
| Basic Average Shares | 0.02%576.30 | 576.40 | 579.20 | -1.40 | 584.70 |
| Diluted Average Shares | 577.60 | 577.60 | 580.70 | -1.40 | 585.70 |
| Basic Earnings Per Share | 26.19%0.53 | 0.42 | 0.66 | 0.16 | 0.50 |
| Diluted Earnings Per Share | 26.19%0.53 | 0.42 | 0.66 | 0.16 | 0.50 |